169 related articles for article (PubMed ID: 31371165)
21. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
Ducharme FM; Hicks GC
Cochrane Database Syst Rev; 2000; (3):CD002314. PubMed ID: 10908555
[TBL] [Abstract][Full Text] [Related]
22. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TSC
BMJ Evid Based Med; 2022 Jun; 27(3):178-184. PubMed ID: 34282031
[TBL] [Abstract][Full Text] [Related]
23. Pragmatic Randomized Controlled Trial for Stepping Down Asthma Controller Treatment in Patients Controlled with Low-Dose Inhaled Corticosteroid and Long-Acting β
Kim SH; Lee T; Jang AS; Park CS; Jung JW; Kim MH; Kwon JW; Moon JY; Yang MS; Lee J; Choi JH; Shin YS; Kim HK; Kim S; Kim JH; Lee SY; Nam YH; Kim SH; Kim TB;
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3638-3646.e3. PubMed ID: 33940213
[TBL] [Abstract][Full Text] [Related]
24. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
25. As-Needed Use of Short-Acting β
Rodríguez-Martínez CE; Sossa-Briceño MP; Buendia JA
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1562-1568. PubMed ID: 35259534
[TBL] [Abstract][Full Text] [Related]
26. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
Papi A; Canonica GW; Maestrelli P; Paggiaro P; Olivieri D; Pozzi E; Crimi N; Vignola AM; Morelli P; Nicolini G; Fabbri LM;
N Engl J Med; 2007 May; 356(20):2040-52. PubMed ID: 17507703
[TBL] [Abstract][Full Text] [Related]
27. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
Murray CS; Thomas M; Richardson K; Price DB; Turner SW
J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
[TBL] [Abstract][Full Text] [Related]
28. Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST.
McKeever T; Mortimer K; Bradshaw L; Haydock R; Pavord I; Higgins B; Walker S; Wilson A; Price D; Thomas M; Devereux G; Brightling C; Renwick C; Parrott S; Mitchell E; Duley L; Harrison T
Health Technol Assess; 2018 Dec; 22(70):1-82. PubMed ID: 30520413
[TBL] [Abstract][Full Text] [Related]
29. A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.
Hanratty CE; Matthews JG; Arron JR; Choy DF; Pavord ID; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Djukanovic R; Gallagher N; Fowler SJ; Hardman TC; Harrison T; Holweg CT; Howarth PH; Lordan J; Mansur AH; Menzies-Gow A; Mosesova S; Niven RM; Robinson DS; Shaw DE; Walker S; Woodcock A; Heaney LG;
Trials; 2018 Jan; 19(1):5. PubMed ID: 29301585
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of beclomethasone dipropionate delivered by breath-actuated or metered-dose inhaler for persistent asthma.
Amar NJ; Moss MH; Kerwin EM; Li J; Small CJ
Allergy Asthma Proc; 2016 Sep; 37(5):359-69. PubMed ID: 27510595
[TBL] [Abstract][Full Text] [Related]
31. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.
Tattersfield AE; Town GI; Johnell O; Picado C; Aubier M; Braillon P; Karlström R
Thorax; 2001 Apr; 56(4):272-8. PubMed ID: 11254817
[TBL] [Abstract][Full Text] [Related]
32. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
33. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
[TBL] [Abstract][Full Text] [Related]
34. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
[TBL] [Abstract][Full Text] [Related]
35. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Li A; Chang AB
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
[TBL] [Abstract][Full Text] [Related]
36. Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial.
Papi A; Nicolini G; Crimi N; Fabbri L; Olivieri D; Rossi A; Paggiaro P
Respir Res; 2012 Jun; 13(1):54. PubMed ID: 22731754
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Salmeterol/fluticasone Combination Therapy in Infants and Preschool Children with Asthma Insufficiently Controlled by Inhaled Corticosteroids.
Yoshihara S; Fukuda H; Tamura M; Arisaka O; Ikeda M; Fukuda N; Tsuji T; Hasegawa S; Kanno N; Teraoka M; Wakiguchi H; Aoki Y; Igarashi H; Terada A; Hasegawa M; Manki A
Drug Res (Stuttg); 2016 Jul; 66(7):371-6. PubMed ID: 27273710
[TBL] [Abstract][Full Text] [Related]
38. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
39. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
Virchow JC; Prasse A; Naya I; Summerton L; Harris A
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
[TBL] [Abstract][Full Text] [Related]
40. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
